Cargando…

Generating a robust prediction model for stage I lung adenocarcinoma recurrence after surgical resection

Lung cancer mortality remains high even after successful resection. Adjuvant treatment benefits stage II and III patients, but not stage I patients, and most studies fail to predict recurrence in stage I patients. Our study included 211 lung adenocarcinoma patients (stages I–IIIA; 81% stage I) who r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yu-Chung, Wei, Nien-Chih, Hung, Jung-Jyh, Yeh, Yi-Chen, Su, Li-Jen, Hsu, Wen-Hu, Chou, Teh-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668084/ https://www.ncbi.nlm.nih.gov/pubmed/29108351 http://dx.doi.org/10.18632/oncotarget.19161

Ejemplares similares

Factors predicting organ-specific distant metastasis in patients with completely resected lung adenocarcinoma
por: Hung, Jung-Jyh, et al.
Publicado: (2016)

Prognostic significance of AKR1B10 in patients with resected lung adenocarcinoma
por: Hung, Jung‐Jyh, et al.
Publicado: (2018)

Prognostic significance of basal versus superior segment in patients with completely resected lung adenocarcinoma in the lower lobe
por: Lin, Yi‐Han, et al.
Publicado: (2019)

Preoperative CT Predicting Recurrence of Surgically Resected Adenocarcinoma of the Lung
por: Koo, Hyun Jung, et al.
Publicado: (2016)

Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis
por: Lin, Chih-Wen, et al.
Publicado: (2020)

Small bowel adenocarcinoma: natural history of recurrence after surgical resection
por: Farina, Massimo, et al.
Publicado: (2022)

Preoperative monocyte count is a predictor of recurrence after Stage I lung adenocarcinoma resection
por: Yoshida, Chihiro, et al.
Publicado: (2022)

Clinical outcomes of surgical resection versus radiofrequency ablation in very-early‐stage hepatocellular carcinoma: a propensity score matching analysis
por: Li, Yuan-Chen, et al.
Publicado: (2021)

Histological and prognostic data on surgically resected early-stage lung adenocarcinoma
por: Yotsukura, Masaya, et al.
Publicado: (2020)

The surgical management of early-stage lung adenocarcinoma: is wedge resection effective?
por: Ji, Ying, et al.
Publicado: (2021)

High O-linked N-acetylglucosamine transferase expression predicts poor survival in patients with early stage lung adenocarcinoma
por: Lin, Yi-Cheng, et al.
Publicado: (2018)

Prognostic implication of EGFR gene mutations and histological classification in patients with resected stage I lung adenocarcinoma
por: Lin, Chun-Yu, et al.
Publicado: (2017)

Genetic and immunologic features of recurrent stage I lung adenocarcinoma
por: Kratz, Johannes R., et al.
Publicado: (2021)

Surgical Resection or Ablation for Recurrent Pancreatic Ductal Adenocarcinoma: An Analysis of Oncologic Outcomes According to the Recurrence Type
por: Lee, Boram, et al.
Publicado: (2021)

Comparison of repeated surgical resection and radiofrequency ablation for small recurrent hepatocellular carcinoma after primary resection
por: Sun, Wei-Chi, et al.
Publicado: (2017)

Predictive factors of recurrence after resection of subsolid clinical stage IA lung adenocarcinoma
por: Im, Dong Jin, et al.
Publicado: (2021)

Role of Chronic Inflammatory Ratios in Predicting Recurrence of Resected Patients with Stage I–III Mucinous Colorectal Adenocarcinoma
por: Liao, Yu-Cui, et al.
Publicado: (2021)

Minor histological components predict the recurrence of patients with resected stage I acinar- or papillary-predominant lung adenocarcinoma
por: Liu, Wei, et al.
Publicado: (2022)

Utility of endoscopic ultrasound for assessment of locoregional recurrence of pancreatic adenocarcinoma after surgical resection
por: Ragheb, Jonathan G., et al.
Publicado: (2023)

A real-world study comparing perioperative chemotherapy and EGFR-tyrosine kinase inhibitors for treatment of resected stage III EGFR-mutant adenocarcinoma
por: Chen, Chieh-Lung, et al.
Publicado: (2023)

Clinicopathological Features and Significance of Epidermal Growth Factor Receptor Mutation in Surgically Resected Early-Stage Lung Adenocarcinoma
por: Lu, Chao-Wen, et al.
Publicado: (2023)

A Qualitative Transcriptional Signature for Predicting Recurrence Risk of Stage I–III Bladder Cancer Patients After Surgical Resection
por: Li, Yawei, et al.
Publicado: (2019)

Surgical resectability of pancreatic adenocarcinoma: CTA
por: Wong, Jimmie C., et al.
Publicado: (2009)

Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis
por: Chen, Yaw-Sen, et al.
Publicado: (2021)

Targeted Next-Generation Sequencing Analysis for Recurrence in Early-Stage Lung Adenocarcinoma
por: Kim, In Ae, et al.
Publicado: (2020)

Prognostic histologic subtyping of dominant tumor in resected synchronous multiple adenocarcinomas of lung
por: Tsai, Ping-Chung, et al.
Publicado: (2021)

Outcomes of patients with different lepidic percentage and tumor size of stage I lung adenocarcinoma
por: Liu, Chia, et al.
Publicado: (2022)

Quantitative Computed Tomography Features for Predicting Tumor Recurrence in Patients with Surgically Resected Adenocarcinoma of the Lung
por: Koo, Hyun Jung, et al.
Publicado: (2017)

Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection
por: Perng, Daw-Shyong, et al.
Publicado: (2021)

Prognostic value of metabolic variables of [18F]FDG PET/CT in surgically resected stage I lung adenocarcinoma
por: Wang, Xiao-Yi, et al.
Publicado: (2017)

Survival after curative resection for stage I colorectal mucinous adenocarcinoma
por: Huang, Liang, et al.
Publicado: (2022)

Resected stage I anaplastic lymphoma kinase‐positive lung adenocarcinoma has a negative impact on recurrence‐free survival
por: Fujibayashi, Yusuke, et al.
Publicado: (2022)

Higher Risk of Tumor Recurrence in NASH-Related Hepatocellular Carcinoma Following Curative Resection
por: Chien, Shih-Chieh, et al.
Publicado: (2022)

Targeted Next-Generation Sequencing Analysis Predicts the Recurrence in Resected Lung Adenocarcinoma Harboring EGFR Mutations
por: Kim, In Ae, et al.
Publicado: (2021)

Circulating tumour cells as an indicator of early and systemic recurrence after surgical resection in pancreatic ductal adenocarcinoma
por: Park, Yejong, et al.
Publicado: (2021)

CXCR4 Expression Predicts Early Liver Recurrence and Poor Survival After Resection of Pancreatic Adenocarcinoma
por: Liao, Wei-Chih, et al.
Publicado: (2012)

Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy
por: Tsai, Ping-Chung, et al.
Publicado: (2022)

Comparative Recurrence Analysis of Pancreatic Adenocarcinoma after Resection
por: He, Chaobin, et al.
Publicado: (2021)

Risk factors of recurrent secondary hyperparathyroidism after adequate primary surgical treatment
por: Kuo, Yu-Chi, et al.
Publicado: (2023)

Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma
por: Veade, Ashley E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sbmob6aanmpa0ji1ekubpnpg86